Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Functional and organic components of diastolic dysfunction in hypertensive heart disease: therapeutic implications
D Sagastagoitia1, M Morillas, N Murga
1Vizcaya Pro-Cardiacos Institute of Cardiology, Hospital Civil de Basurto, Bilbao, Bizkaia, Spain.
Insights
Hypertension impairs left ventricular diastolic function through structural and functional changes. Drug therapy initially improves function by targeting functional determinants, with long-term benefits from structural modifications.
Area of Science:
- Cardiology
- Hypertension Research
- Diastolic Dysfunction
Background:
- Hypertension is a major risk factor for cardiovascular disease.
- Left ventricular diastolic dysfunction is a common complication of hypertension.
- Understanding the determinants of diastolic dysfunction is crucial for effective management.
Purpose of the Study:
- To review the structural and functional determinants of impaired left ventricular diastolic function in hypertensive patients.
- To discuss the indices used for detecting diastolic dysfunction.
- To elucidate the impact of therapeutic interventions on these determinants.
Main Methods:
- Literature review of studies on hypertensive heart disease.
- Analysis of physiological and structural changes affecting diastolic function.
- Examination of the effects of pharmacological interventions.
Main Results:
- Impaired diastolic function in hypertension involves both structural and functional determinants.
- Functional determinants are amenable to rapid modification.
- Structural determinants require long-term interventions for modification.
Conclusions:
- Drug therapy for hypertension initially targets functional determinants of diastolic dysfunction.
- Sustained therapeutic efforts lead to the modification of structural factors.
- This dual action of therapy results in long-term improvement of left ventricular diastolic function.
Abstract:
The major structural and functional determinants of impaired left ventricular diastolic function in the hypertensive patient are reviewed, together with the indices normally used to detect this failure. The alteration of functional determinants can be quickly modified, while structural determinants are modified only over the long term. Drug therapy first affects the functional determinants, bringing about their attenuation and initiating the modification of the structural factors, thus accounting for the improvement in diastolic function over the long term.
More Related Videos
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
11:04Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
Published on: September 1, 2014
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Small interfering RNAs (siRNA)
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Hepatic Drug Excretion: Influencing Factors